Health Care/Hospital News & Press Release Distribution

Health Care/Hospital

APAC
Global

Inovalon Applauded by Frost & Sullivan for Improving Healthcare Delivery, Patient Outcomes, and Data Security with Its Inovalon ONE® Platform

Inovalon ONE® Platform seamlessly aggregates, standardizes, and analyzes diverse data to gain meaningful insights, support evidence-based decision-making, and offer data security and privacy. SAN ANTONIO, Dec. 11, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the healthcare analytics...

2023-12-11 22:00 1291

Yingli Pharma presents a pivotal Phase 2 study data evaluating linperlisib in relapsed or refractory peripheral T-cell lymphoma in an oral session at the American Society of Hematology 2023 Annual Meeting

Linperlisib achieved Overall Response Rate of 48% with 30% being Complete Response and manageable safety profile in the r/r PTCL phase 2 study SHANGHAI and SAN FRANCISCO, Dec. 11, 2023 /PRNewswire/ -- Shanghai Yingli Pharmaceutical Co., Ltd. ("Yingli Pharma"), a biopharmaceutical company focused ...

2023-12-11 21:00 1305

Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments

SHANGHAI, Dec. 11, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin"),...

2023-12-11 21:00 2382

Mabwell Announces the CDE Approval of Novel Nectin-4 Targeting ADC for Phase III Clinical Trial

SHANGHAI, Dec. 11, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its submission to the Center for Drug Evaluation (CDE) of the National Medical Products Administration for the "A Randomized, Open-label, Controlled, Mu...

2023-12-11 20:00 1080

HanAll Biopharma's Partner, NurrOn Pharmaceuticals Incorporated Appoints Dr. Almira Chabi, MD, EGMP to Board of Directors

WOBURN, Mass., Dec. 11, 2023 /PRNewswire/ -- HanAll Biopharma's partner NurrOn Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to developing novel, targeted therapeutics for the treatment of Parkinson's disease (PD) and other Nurr1-related human disorders, is pleased to...

2023-12-11 20:00 1106

First Patient Dosed in U.S. Expanded Access Program for TLX250-CDx, Telix's Breakthrough Kidney Cancer Imaging Agent

MELBOURNE, Australia and INDIANAPOLIS, Dec. 11, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in aUnited States (U.S.) expanded access program (EAP, ClinicalTrials.gov ID:NCT06090331

2023-12-11 19:40 1215

2023 SABCS | Laekna Reports Afuresertib Phase Ib Breast Cancer Study Results

- A multi-center phase Ib/III study in China and the United States led by ProfessorBinghe Xu, MD, PhD, Academician of the Chinese Academy of Engineering - 70% of the patients enrolled in phase Ib study were previously treated with CDK4/6 inhibitors - Demonstrated a confirmed objecti...

2023-12-11 18:55 1101

Hummingbird Bioscience Strengthens Leadership Team with Appointment of Angèle Maki as Chief Business Officer

SAN FRANCISCO and SINGAPORE, Dec. 11, 2023 /PRNewswire/ -- Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases, today announced the appointment of Angèle Maki, Ph.D., as Chief Business Offi...

2023-12-11 18:00 1362

Live from ASH 2023 | Ascentage Pharma Presents Updated Data from US Study of Olverembatinib, Further Validating Encouraging Efficacy in Patients Resistant to Ponatinib or Asciminib

SUZHOU, China, and ROCKVILLE, Md., Dec. 10, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released updated data from a US study ...

2023-12-11 13:30 1119

Live from ASH 2023 | Ascentage Pharma Releases Encouraging Long-Term Data of Bcl-2 Inhibitor Lisaftoclax in R/R CLL, Including an ORR of 73.3%

SUZHOU, China and ROCKVILLE, Md., Dec. 10, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released the latest efficacy and safety...

2023-12-11 13:14 1114

MGI Expands Presence in Latin America with New Partnerships with Genos Médica and TCL Group

SAO PAULO, Dec. 10, 2023 /PRNewswire/ -- MGI Tech Co. Ltd., a company committed to building core tools and technology to lead life science, today announced partnerships with Genos Médica, aMexico-based specialized center in genomics, and TCL Group, a company dedicated to the import and sales of l...

2023-12-11 11:26 1150

MGI Expands Presence in Latin America with New Partnerships with Genos Médica and TCL Group

Global Times: TV drama 'Welcome to Milele' represents decades-old China-Africa medical aid cooperation

BEIJING, Dec. 11, 2023 /PRNewswire/ -- This year marks the 60th anniversary sinceChina sent its first medical team to aid Algeria on April 6, 1963. Over the past six decades, China has dispatched over 30,000 medical professionals to 76 countries and regions across the world. Currently, Chinese m...

2023-12-11 09:01 1306

Nona Biosciences Announces Collaboration with Evive Biotech to Accelerate Antibody Discovery

CAMBRIDGE, Mass., Dec. 10, 2023 /PRNewswire/ -- Nona Biosciences, a global pioneer of technology innovation and antibody discovery and development solutions, and Evive Biotech, a global biopharmaceutical company devoted to developing a portfolio of novel biological therapies for patients worldwid...

2023-12-11 09:00 1073

Antengene Announces the Study of Anti-CD24 Monoclonal Antibody ATG-031 Dosed Its First Patient in the United States

* The Phase I PERFORM trial, taking place at four clinical trial centers across the U.S., will evaluate the safety and preliminary efficacy of ATG-031 in patients withadvanced solid tumors or B-cell non-Hodgkin's lymphoma (B-NHL). * ATG-031, discovered and developed in-house by Antengene, is t...

2023-12-11 08:30 1352

Dizal's Golidocitinib Pivotal Trial Demonstrates Superior and Durable Clinical Benefits for Patients with r/r PTCL in Oral Presentation at 2023 ASH

* Full analysis of multinational pivotal study results of golidocitinib in relapsed or refractory peripheral T-cell lymphoma (r/r PTCL) (JACKPOT8 PART B) simultaneously published inThe Lancet Oncology and presented in oral session at the 65th American Society of Hematology Annual Meeting and Ex...

2023-12-10 18:00 1349

Menarini Group Presents New Progression-Free Survival Data from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Clinically Relevant Subgroups of Patients with ER+, HER2- Metastatic Breast Cancer (mBC) with ESR1 Mutations at SABCS 2023

* This new post hoc analysis of the Phase 3 EMERALD trial evaluated elacestrant in the endocrine-sensitive population (CDK4/6 inhibitor duration of at least 12 months) with tumors harboring ESR1 mutations. * This analysis shows a clinically meaningful improvement in progression-free survivala...

2023-12-08 23:13 3320

RewirEd Summit at COP28 makes history by bringing education to the forefront of climate action to impact billions of children and youth globally

DUBAI, UAE, Dec. 8, 2023 /PRNewswire/ -- RewirEd Summit, the first ever global education summit on climate brought together 1,000 participants, including 2 heads of state, 22 ministers, and 28 CEOs, with 260 speakers from diverse sectors, representing 209 entities and 76 countries, to address urg...

2023-12-08 22:06 2183

RewirEd Summit at COP28 makes history by bringing education to the forefront of climate action to impact billions of children and youth globally

WuXi Biologics Awarded Highest Platinum Medal by EcoVadis Sustainability Rating

* Ranked in top 1% of the over 100,000 companies evaluated * Recognized for outstanding performance across all areas: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement * Seen as a trusted partner by global clients for its strong sustainability commitment SHANGHAI, Dec. 8...

2023-12-08 17:40 3532

Whole Exome Sequencing Advancements in Unraveling Rare Diseases in Japan

TOKYO, Dec. 8, 2023 /PRNewswire/ -- According to Estimation of the Number of Patients With Mitochondrial Diseases: A Descriptive Study Using in a nationwide database inJapan , 2.9 out of every 100,000 people inJapan ...

2023-12-08 13:40 1646

PharmaBlock Officially Joins United Nations Global Compact

NANJING, China, Dec. 8, 2023 /PRNewswire/ -- PharmaBlock Sciences (Nanjing), Inc. (Stock code: 300725.SZSE), a global, fully integrated CRDMO company, focusing on innovative chemistry and low-carbon manufacturing, has officially joined the United Nations Global Compact (UNGC), which not only affi...

2023-12-08 12:37 1254

1 ... 55 56 575859 60 61 ... 808